🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of this trial are: to establish a safety profile for use of ...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2004-01
Trial ID
NCT00568802
Treatments Being Tested
To conduct a randomized controlled internal pilot feasibility trial for the...
Status
Completed
Location
Aminu Kano Teaching Hospital
Start Date
2022-04-01
Trial ID
NCT05142254
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of bomedem...
Status
Active Not Recruiting
Location
Palo Verde Cancer Specialists ( Site 0052)
Start Date
2024-07-16
Trial ID
NCT06456346
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of 2 doses ...
Status
Active Not Recruiting
Location
Childrens Healthcare of Atlanta
Start Date
2019-07-26
Trial ID
NCT03814746
Treatments Being Tested
The purpose of this study is to determine if hydroxyurea therapy is effecti...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2000-08
Trial ID
NCT00006400
Treatments Being Tested
Multiple studies have shown that hydroxyurea has clinical efficacy in preve...
Status
Completed
Location
Mulago Hospital Sickle Cell Clinic
Start Date
2014-09
Trial ID
NCT01976416
Treatments Being Tested
140 SCD patients \[70 on Hydroxyurea\] will receive Omega-3 capsules wherea...
Status
Unknown
Location
Department of Haematology, Sultan Qaboos University
Start Date
2015-09
Trial ID
NCT02525107
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ruxolit...
Status
Terminated
Location
Mayo Clinic
Start Date
2017-11-14
Trial ID
NCT03123588
Treatments Being Tested
Sickle cell disease (SCD), also known as sickle cell anemia, is an inherite...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2007-01
Trial ID
NCT00532883
Treatments Being Tested
This study is to determine the efficacy of Jaktinib versus Hydroxycarbamid ...
Status
Completed
Location
The First Affiliated Hospital of Medical School of Zhejiang University
Start Date
2021-02-05
Trial ID
NCT04617028
Treatments Being Tested